Key facts
- This page summarizes Ye Wang's Form 3 filing for Legend Biotech Corp (LEGN).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 18:48.
Ye Wang - 18 Mar 2026 Form 3 Insider Report for Legend Biotech Corp (LEGN)
- Reporting relationship
- Director
- Issuer ticker
- LEGN
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ James Pepin, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ye Wang filed Form 3 for Legend Biotech Corp (LEGN) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002114160
Primary reporting owner
Wang Ye
- Relationship
- Director
- Address
- C/O LEGEND BIOTECH CORP, 2101 COTTONTAIL LANE, SOMERSET
- Signature
- /s/ James Pepin, Attorney-in-Fact
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LEGN
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 16
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
SEC remarks
Exhibit 24 - Power of Attorney